Rare sugars curb appetite and mimic diabetes drugs in mice
Rare sugars like D-allulose, D-tagatose, and D-sorbose significantly boosted GLP-1 secretion and suppressed food intake in mice. D-allose also reduced food intake through a unique, GLP-1-independent pathway.
HIMS Expands Telehealth Offerings with Eli Lilly’s GLP-1 Drugs
Related Stocks: HIMS,
GLP-1 spending hits $5.8B for adults without diabetes
A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 among U.S. adults without diabetes. The research, published April 1 in the Annals of Internal Medicine, showed the number of non-diabetic adults using these drugs — which are also prescribed for weight loss — […]
Eli Lilly sues Empower, Strive over tirzepatide products
Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded versions of the obesity drug tirzepatide in combinations or forms that haven’t been …
I dropped 4 stone on fat jabs – people say it’s the ‘best glow-up’ they’ve seen but I had a very unexpected side effect
A 29-YEAR-OLD has revealed that she lost over four stone after using Mounjaro for six months. Jasmine Hannah, a woman from the UK, confirmed that she once topped the scales at 17st 11 lbs. tiktok/@jasminehannah08A young woman has proudly shared her weight loss transformation after using Mounjaro[/caption] tiktok/@jasminehannah08Jasmine Hannah lost 4 stone 8 lbs, and […]
Here’s how much Ozempic and similar drugs have soared in popularity since 2018
The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion. Read more…
FDA Approves Semaglutide to Reduce Risk of Kidney Disease Progression
Semaglutide, marketed as Ozempic, recently became the first glucagon-like peptide 1 (GLP-1) receptor agonist approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), a common complication of […]
Labor Smart Targets GLP-1 Market with Functional Gummies – Pre-Orders Begin April 7th
Related Stocks: OTCPK:LTNC,
Costly GLP-1 drug use for weight loss has soared, study reports
The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.
Largest single-cell map of the aging brain reveals vulnerable cell types and regions
A new study published in Nature offers the most detailed map to date of how individual cell types in the brain change with age. Scientists analyzed over 1.2 million brain cells from young and aged mice and found that many specific cells undergo significant gene expression changes as animals grow older. These changes were not […]